Leap Therapeutics (LPTX) Misses Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts LPTX Hot Sheet
Join SI Premium – FREE
Leap Therapeutics (NASDAQ: LPTX) reported Q3 EPS of ($0.08).
For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iambic Therapeutics (IAM) files for proposed IPO
- National Bank Financial Starts Canadian Net REIT (NET-U:CN) at Sector Perform
- Wolverine World Wide eliminates Active Group president role
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
